Found 10 matching trials
Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris
PHASE2To evaluate the safety and effectiveness of 3 strengths of P005672-HCl comp...
Location
Warner Chilcott Investigational Site
Sarecycline Truncal Acne Safety and Efficacy Response
N/AThe purpose of this study is to determine the efficacy and safety of oral s...
Location
Arlington Research Center
Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
PHASE3To evaluate the efficacy and safety of an approximate 1.5 mg/kg/day dose of...
Location
Warner Chilcott Research Site (Site #206)
Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
PHASE3To evaluate the efficacy and safety of an approximate 1.5mg/kg/day dose of ...
Location
Warner Chilcott Research Site (Site #155)
Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
PHASE4A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerabil...
Location
The Dermatology Institute of Boston
A Pilot Study on the Use of Seysara for Rosacea
PHASE4This is a prospective, parallel group, randomized, investigator-blinded pil...
Location
Skin Sciences, PLLC
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
PHASE4This study is being done to help better understand how the gut and skin bac...
Location
Integrative Research Institute
Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)
N/AThe purpose of this study is to evaluate the patient-reported outcomes (PRO...
Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy
PHASE2The aim of this study was to evaluate the efficacy and safety of Sarecyclin...
Location
Beijing Tiantan Hospital
A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris
PHASE3Open-label study will evaluate the safety of an approximate 1.5 mg/kg/day d...
Location
Actavis Investigational Study Site #206